Global Artificial Pancreas Device System (APDS) Market Growth (Status and Outlook) 2023-2029

Global Artificial Pancreas Device System (APDS) Market Growth (Status and Outlook) 2023-2029

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

LPI (LP Information)' newest research report, the “Artificial Pancreas Device System (APDS) Industry Forecast” looks at past sales and reviews total world Artificial Pancreas Device System (APDS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Pancreas Device System (APDS) sales for 2023 through 2029. With Artificial Pancreas Device System (APDS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Pancreas Device System (APDS) industry.

This Insight Report provides a comprehensive analysis of the global Artificial Pancreas Device System (APDS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Pancreas Device System (APDS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Pancreas Device System (APDS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Pancreas Device System (APDS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Pancreas Device System (APDS).

The global Artificial Pancreas Device System (APDS) market size is projected to grow from US$ 70 million in 2022 to US$ 159.8 million in 2029; it is expected to grow at a CAGR of 12.6% from 2023 to 2029.

The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.

Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.

North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Device System (APDS) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems

Segmentation by application
Hospitals
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed

Please note: The report will take approximately 2 business days to prepare and deliver.